| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| NAGE | NAGE | Shares | USD | XNCM |
| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| NAGE | NAGE | Shares | USD | XNCM |
Niagen Bioscience, Inc. specializes in the research and development of NAD+ (nicotinamide adenine dinucleotide) science and its applications in health and aging. The company produces and commercializes dietary supplements, notably its patented ingredient Niagen®, which is designed to restore and optimize NAD+ levels in the body. Niagen Bioscience serves various markets, including dietary supplements, food, beverages, skin care, and pharmaceuticals, and collaborates with academic institutions and industry leaders to advance its scientific research. The company operates globally, focusing on improving healthspan through evidence-based solutions.
No recent RNS announcements for NAGE across NAGE.
No recent RNS announcements for NAGE across NAGE.